Table 1.
Baseline characteristics and anesthetic agents received (all-subjects-treated group)
| |
Chinese |
Caucasian |
||
|---|---|---|---|---|
| Sugammadex (n = 120) | Neostigmine (n = 111) | Sugammadex (n = 29) | Neostigmine (n = 31) | |
| Gender (n, %) |
|
|
|
|
| Female |
78 (65) |
86 (77) |
25 (86) |
28 (90) |
| Male |
42 (35) |
25 (23) |
4 (14) |
3 (10) |
| Race (n, %) |
|
|
|
|
| White |
0 (0) |
0 (0) |
29 (100) |
31 (100) |
| Asian |
120 (100) |
111 (100) |
0 (0) |
0 (0) |
| Age (Mean, SD years) |
39.9 (10.8) |
39.4 (10.8) |
52.0 (10.3) |
51.9 (7.3) |
| Weight (Mean, SD kg) |
62.8 (12.6) |
61.3 (11.3) |
72.8 (10.8) |
72.7 (11.8) |
| Height (Mean, SD cm) |
163.8 (7.7) |
163.7 (6.7) |
169.1 (6.6) |
167.9 (6.8) |
| BMI (mean, SD kg/m2) |
23.3 (3.6) |
22.8 (3.3) |
25.5 (3.5) |
25.9 (4.3) |
| ASA class (n, %) |
|
|
|
|
| 1 |
90 (75) |
82 (74) |
12 (41) |
16 (52) |
| 2 |
28 (23) |
29 (26) |
15 (52) |
15 (48) |
| 3 |
2 (2) |
0 (0) |
2 (7) |
0 (0) |
| Anesthetic agents received (n, %) |
|
|
|
|
| Propofol |
120 (100) |
111 (100) |
29 (100) |
31 (100) |
| Remifentanil |
101 (84) |
92 (83) |
20 (69) |
23 (74) |
| Fentanyl |
65 (54) |
66 (59) |
7 (24) |
10 (32) |
| Sufentanyl |
41 (34) |
38 (34) |
9 (31) |
8 (26) |
| Tramadol |
2 (2) |
3 (3) |
0 (0) |
0 (0) |
| Butorphanol | 0 (0) | 1 (1) | 0 (0) | 0 (0) |
ASA: American Society of Anesthesiologists; BMI: Body mass index; SD: Standard deviation.